Einde inhoudsopgave
Convention on Psychotropic Substances
Schedules of the Convention on Psychotropic Substances of 1971, as at 13 November 2023
Geldend
Geldend van 13-11-2023 tot 03-12-2024
- Bronpublicatie:
15-03-2023, Trb. 2023, 112 (uitgifte: 26-09-2023, kamerstukken/regelingnummer: -)
- Inwerkingtreding
13-11-2023
- Bronpublicatie inwerkingtreding:
15-03-2023, Trb. 2023, 112 (uitgifte: 26-09-2023, kamerstukken/regelingnummer: -)
- Vakgebied(en)
Internationaal publiekrecht / Verdragenrecht
Internationaal strafrecht / Bijzondere onderwerpen
Lists of substances in the Schedules
International non-proprietary name (INN) | Other non-proprietary or trivial names | Chemical name |
---|---|---|
25B-NBOMe, 2C-B-NBOMe | 2-(4-Bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine | |
Brolamfetamine | DOB | (±)-4-Bromo-2,5-dimethoxy-α-methylphenethylamine |
25C-NBOMe, 2C-C-NBOMe | 2-(4-Chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine | |
Cathinone | (−)-(S)-2-Aminopropiophenone | |
DET | 3-[2-(Diethylamino)ethyl]indole | |
DMA | (±)-2,5-Dimethoxy-α-methylphenethylamine | |
DMHP | 3-(1,2-Dimethylheptyl)-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran-1-ol | |
DMT | 3-[2-(Dimethylamino)ethyl]indole | |
DOC | 1-(4-Chloro-2,5-dimethoxyphenyl)propan-2-amine | |
DOET | (±)-4-Ethyl-2,5-dimethoxy-α-methylphenethylamine | |
Eticyclidine | PCE | N-Ethyl-1-phenylcyclohexylamine |
Etryptamine | 3-(2-Aminobutyl)indole | |
N-Hydroxy MDA | (±)-N-[α-Methyl-3,4-(methylenedioxy)phenethyl]hydroxylamine | |
25I-NBOMe, 2C-I-NBOMe | 2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine | |
(+)-Lysergide | LSD, LSD-25 | 9,10-Didehydro-N,N-diethyl-6-methylergoline-8β-carboxamide |
MDE,N-Ethyl MDA | (±)-N-Ethyl-α-methyl-3,4-(methylenedioxy)phenethylamine | |
MDMA | (±)-N,α-Dimethyl-3,4-(methylenedioxy)phenethylamine | |
Mescaline | 3,4,5-Trimethoxyphenethylamine | |
Methcathinone | 2-(Methylamino)-1-phenylpropan-1-one | |
4-Methylaminorex | (±)-cis-2-Amino-4-methyl-5-phenyl-2-oxazoline | |
MMDA | 5-Methoxy-α-methyl-3,4-(methylenedioxy)phenylethylamine | |
4-MTA | α-Methyl-4-methylthiophenethylamine | |
Parahexyl | 3-Hexyl-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran-1-ol | |
para-Methoxymethylamphetamine, PMMA | 1-(4-Methoxyphenyl)-N-methylpropan-2-amine | |
PMA | p-Methoxy-α-methylphenylethylamine | |
Psilocine, psilotsin | 3-[2-(Dimethylamino)ethyl]indol-4-ol | |
Psilocybine | 3-[2-(Dimethylamino)ethyl]indol-4-yl hydrogen phosphate | |
Rolicyclidine | PHP, PCPY | 1-(1-Phenylcyclohexyl)pyrrolidine |
STP, DOM | 2,5-Dimethoxy-α,4-dimethylphenethylamine | |
Tenamfetamine | MDA | α-Methyl-3,4-(methylenedioxy)phenethylamine |
Tenocyclidine | TCP | 1-[1-(2-Thienyl)cyclohexyl]piperidine |
Tetrahydrocannabinol, the following isomers and their stereochemical variants: | ||
7,8,9,10-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol 8,9,10,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol | ||
6a,9,10,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol | ||
6a,7,10,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol | ||
6a,7,8,9-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol | ||
6a,7,8,9,10,10a-Hexahydro-6,6-dimethyl-9-methylene-3-pentyl-6H-dibenzo[b,d]pyran-1-ol | ||
TMA | (±)-3,4,5-Trimethoxy-α-methylphenethylamine |
The salts of the substances listed in this Schedule whenever the existence of such salts is possible.
The stereoisomers, unless specifically excepted, of substances in this Schedule, whenever the existence of such stereoisomers is possible within the specific chemical designation.
International non-proprietary name (INN) | Other non-proprietary or trivial names | Chemical name |
---|---|---|
α-Pyrrolidinovalerophenone, α- PVP | 1-Phenyl-2-(pyrrolidin-1-yl)pentan-1-one | |
AB-CHMINACA | N-[(2S)-1-Amino-3-methyl-1-oxobutan-2-yl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide | |
AB-FUBINACA | N-[1-Amino-3-methyl-1-oxobutan-2-yl]-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide | |
AB-PINACA | N-[(2S)-1-Amino-3-methyl-1-oxobutan-2-yl]-1-pentyl-1H-indazole-3-carboxamide | |
ADB-BUTINACA | N-[1-(Aminocarbonyl)-2,2-dimethylpropyl]-1-butyl-1H-indazole-3-carboxamide | |
ADB-CHMINACA (MAB-CHMINACA) | N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide | |
ADB-FUBINACA | N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-1-[(4-fluorophenyl)methyl]-1H-indazole-3- carboxamide | |
alpha-PiHP | 4-Methyl-1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one | |
alpha-PHP | 1-Phenyl-2-(pyrrolidin-1-yl)hexan-1-one | |
AM-2201 | 1-(5-Fluoropentyl)-1H-indol-3-yl]-(naphthalen-1-yl)methanone | |
Amfetamine | Amphetamine | (±)-α-Methylphenethylamine |
Amineptine | 7-[(10,11-Dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid | |
N-Benzylpiperazine, BZP | 1-Benzylpiperazine | |
2C-B | 4-Bromo-2,5-dimethoxyphenethylamine | |
4-CMC (4-chloromethcathinone, clephedrone) | 1-(4-Chlorophenyl)-2-(methylamino)propan-1-one | |
CUMYL-4CN-BINACA | 1-(4-Cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide | |
CUMYL-PEGACLONE | 5-Pentyl-2-(2-phenylpropan-2-yl)-2,5-dihydro-1H-pyrido[4,3-b]indol-1-one | |
Dexamfetamine | Dexamphetamine | (+)-α-Methylphenethylamine |
Diphenidine | 1-(1,2-Diphenylethyl)piperidine | |
Dronabinol(*1) | delta-9-Tetrahydro-cannabinol and its stereochemical variants | (6aR,10aR)-6a,7,8,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d] pyran-1-ol |
N-Ethylhexedrone | 2-(Ethylamino)-1-phenylhexan-1-one | |
N-Ethylnorpentylone (ephylone) | 1-(2H-1,3-Benzodioxol-5-yl)-2-(ethylamino)pentan-1-one | |
Ethylone | 1-(2H-1,3-Benzodioxol-5-yl)-2-(ethylamino)propan-1-one | |
Ethylphenidate | Ethyl phenyl(piperidin-2-yl)acetate | |
Eutylone | 1-(1,3-Benzodioxol-5-yl)-2-(ethylamino)butan-1-one | |
4-Fluoroamphetamine (4-FA) | 1-(4-Fluorophenyl)propan-2-amine | |
4F-MDMB-BINACA | Methyl 2-{[1-(4-fluorobutyl)-1H-indazole-3-carbonyl]amino}-3,3-dimethylbutanoate | |
5F-AMB-PINACA (5F-AMB, | ||
5F-MMB-PINACA) | Methyl 2-{[1-(5-fluoropentyl)-1H-indazole-3-carbonyl]amino}-3-methylbutanoate | |
5F-APINACA (5F-AKB-48) | N-(Adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide | |
5F-MDMB-PICA (5F-MDMB-2201) | Methyl 2-{[1-(5-fluoropentyl)-1H-indole-3-carbonyl]amino}-3,3-dimethylbutanoate | |
5F-MDMB-PINACA (5F-ADB), | Methyl (2S)-2-{[1-(5-fluoropentyl)-1H-indazole-3-carbonyl]amino}-3,3-dimethylbutanoate | |
Fenetylline | 7-[2-[(α-Methylphenethyl)amino]ethyl]theophylline | |
5F-PB-22 | Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate | |
FUB-AMB (MMB-FUBINACA, AMB-FUBINACA) | Methyl (2S)-2-({1-[(4-fluorophenyl)methyl]-1H-indazole-3-carbonyl}amino)-3-methylbutanoate | |
GHB | γ-Hydroxybutyric acid | |
JWH-018 | Naphthalen-1-yl(1-pentyl-1H-indol-3-yl)methanone | |
Levamfetamine | Levamphetamine | (−)-(R)-α-Methylphenethylamine |
Levomethamphetamine | (−)-N,α-Dimethylphenethylamine | |
MDMB-CHMICA | Methyl N-{[1-(cyclohexylmethyl)-1H-indol-3-yl]carbonyl}-3-methyl-L-valinate | |
MDMB-4en-PINACA | Methyl 3,3-dimethyl-2-(1- (pent-4-en-1-yl)-1H-indazole-3- carboxamido)butanoate | |
Mecloqualone | 3-(o-Chlorophenyl)-2-methyl-4(3H)Quinazolinone | |
Mephedrone, | (RS)-2-(Methylamino)-1-(4-methylphenyl)propan-1-one | |
4-methylmethcathinone | ||
Metamfetamine | Methamphetamine | (+)-(S)-N,α-Dimethylphenethylamine |
Metamfetamine racemate | Methamphetamine racemate | (±)-N,α-Dimethylphenethylamine |
Methaqualone | 2-Methyl-3-o-tolyl-4(3H)quinazolinone | |
Methiopropamine (MPA) | N-Methyl-1-(thiophen-2-yl)propan-2-amine | |
Methoxetamine, MXE | 2-(Ethylamino)-2-(3-methoxyphenyl)cyclohexanone | |
3-Methoxyphencyclidine | 1-(1-(3-Methoxyphenyl)cyclohexyl)piperidine | |
3,4-Methylenedioxypyro-valerone, MDPV | (RS)-1-(Benzo[d][1,3]dioxol-5-yl)-2-(pyrrolidin-1-yl)pentan-1-one | |
4-Methylethcathinone (4-MEC) | 2-(Ethylamino)-1-(4-methylphenyl) propan-1-one | |
3-Methylmethcathinone | 2-(Methylamino)-1-(3-methylphenyl)propan-1-one | |
Methylone, beta-keto-MDMA | (RS)-2-Methylamino-1-(3,4-methylenedioxyphenyl)propan-1-one | |
Methylphenidate | Methyl α-phenyl-2-piperidine acetate | |
para-Methyl-4-methylaminorex, 4,4'-DMAR | 4-Methyl-5-(4-methylphenyl)-4,5-dihydro-1,3-oxazol-2-amine | |
Pentedrone | 2-(Methylamino)-1-phenylpentan-1-one | |
Phencyclidine | PCP | 1-(1-Phenylcyclohexyl)piperidine |
Phenmetrazine | 3-Methyl-2-phenylmorpholine | |
Secobarbital | 5-Allyl-5-(1-methylbutyl)barbituric acid | |
UR-144 | 1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl) methanone | |
XLR-11 | [1-(5-Fluoropentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl) methanone | |
Zipeprol | α-(α-Methoxybenzyl)-4-(β-methoxyphenethyl)-1-piperazineethanol |
The salts of the substances listed in this Schedule whenever the existence of such salts is possible.
International non-proprietary name (INN) | Other non-proprietary or trivial names | Chemical name |
---|---|---|
Amobarbital | 5-Ethyl-5-isopentylbarbituric acid | |
Buprenorphine | 21-Cyclopropyl-7α-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine | |
Butalbital | 5-Allyl-5-isobutylbarbituric acid | |
Cathine | (+)-Norpseudo-ephedrine | (+)-(S)-α-[(S)-1-Aminoethyl]benzylalcohol |
Cyclobarbital | 5-(l-Cyclohexen-l-yl)-5-ethylbarbituric acid | |
Flunitrazepam | 5-(o-Fluorophenyl)-1,3-dihydro-1-methyl-7-nitro-2H-1,4-benzodiazepin-2-one | |
Glutethimide | 2-Ethyl-2-phenylglutarimide | |
Pentazocine | (2R*,6R*,11R*)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol | |
Pentobarbital | 5-Ethyl-5-(1-methylbutyl)barbituric acid |
The salts of the substances listed in this Schedule whenever the existence of such salts is possible.
International non-proprietary name (INN) | Other non-proprietary or trivial names | Chemical name |
---|---|---|
Allobarbital | 5,5-Diallylbarbituric acid | |
Alprazolam | 8-Chloro-1-methyl-6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepine | |
Amfepramone | Diethylpropion | 2-(Diethylamino)propiophenone |
Aminorex | 2-Amino-5-phenyl-2-oxazoline | |
Barbital | 5,5-Diethylbarbituric acid | |
Benzfetamine | Benzphetamine | N-Benzyl-N-α-dimethylphenethylamine |
Bromazepam | 7-Bromo-1,3-dihydro-5-(2-pyridyl)-2H-1,4-benzodiazepin-2-one | |
Brotizolam | 2-Bromo-4-(o-chlorophenyl)-9-methyl-6H-thieno[3,2-f]-s-triazolo[4,3-a][1,4]diazepine | |
Butobarbital | 5-Butyl-5-ethylbarbituric acid | |
Camazepam | 7-Chloro-1,3-dihydro-3-hydroxy-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one dimethylcarbamate (ester) | |
Chlordiazepoxide | 7-Chloro-2-methylamino-5-phenyl-3H-1,4- benzodiazepine-4-oxide | |
Clobazam | 7-Chloro-1-methyl-5-phenyl-1H-1,5-benzodiazepine-2,4(3H,5H)-dione | |
Clonazepam | 5-(o-Chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one | |
Clonazolam | 6-(2-Chlorophenyl)-1-methyl-8-nitro-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine | |
Clorazepate | 7-Chloro-2,3-dihydro-2-oxo-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid | |
Clotiazepam | 5-(o-Chlorophenyl)-7-ethyl-1,3-dihydro-1-methyl-2H-thieno[2,3-e]-1,4-diazepin-2-one | |
Cloxazolam | 10-Chloro-11b-(o-chlorophenyl)-2,3,7,11b-tetrahydrooxazolo-[3,2-d][1,4]benzodiazepin-6(5H)-one | |
Delorazepam | 7-Chloro-5-(o-chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one | |
Diazepam | 7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one | |
Diclazepam | 7-Chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro-2H-benzo[e][1,4]diazepin2-one | |
Estazolam | 8-Chloro-6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepine | |
Ethchlorvynol | 1-Chloro-3-ethyl-1-penten-4-yn-3-ol | |
Ethinamate | 1-Ethynylcyclohexanolcarbamate | |
Ethyl loflazepate | Ethyl 7-chloro-5-(o-fluorophenyl)-2,3-dihydro-2-oxo-1H-1,4-benzodiazepine-3-carboxylate | |
Etilamfetamine | N-Ethylamphetamine | N-Ethyl-α-methylphenethylamine |
Etizolam | 4-(2-Chlorophenyl)-2-ethyl-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine | |
Fencamfamin | N-Ethyl-3-phenyl-2-norbornanamine | |
Fenproporex | (±)-3-[(α-Methylphenethyl)amino]propionitrile | |
Flualprazolam | 8-Chloro-6-(2-fluorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4] diazepine | |
Flubromazolam | 8-Bromo-6-(2-fluorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine | |
Fludiazepam | 7-Chloro-5-(o-fluorophenyl)-1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one | |
Flurazepam | 7-Chloro-1-[2-(diethylamino)ethyl]-5-(o-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one | |
Halazepam | 7-Chloro-1,3-dihydro-5-phenyl-1-(2,2,2-trifluoroethyl)-2H-1,4-benzodiazepin-2-one | |
Haloxazolam | 10-Bromo-11b-(o-fluorophenyl)-2,3,7,11b-tetrahydrooxazolo[3,2-d][1,4]benzodiazepin-6(5H)-one | |
Ketazolam | 11-Chloro-8,12b-dihydro-2,8-dimethyl-12b-phenyl-4H-[1,3]oxazino[3,2-d][1,4]benzodiazepine-4,7(6H)-dione | |
Lefetamine | SPA | (−)-N,N-Dimethyl-1,2-diphenylethylamine |
Loprazolam | 6-(o-Chlorophenyl)-2,4-dihydro-2-[(4-methyl-1-piperazinyl)methylene]-8-nitro-1H-imidazo[1,2-a][1,4]benzodiazepin-1-one | |
Lorazepam | 7-Chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one | |
Lormetazepam | 7-Chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-1-methyl-2H-1,4-benzodiazepin-2-one | |
Mazindol | 5-(p-Chlorophenyl)-2,5-dihydro-3H-imidazo[2,1-a]isoindol-5-ol | |
Medazepam | 7-Chloro-2,3-dihydro-1-methyl-5-phenyl-1H-1,4-benzodiazepine | |
Mefenorex | N-(3-Chloropropyl)-α-methylphenethylamine | |
Meprobamate | 2-Methyl-2-propyl-1,3-propanedioldicarbamate | |
Mesocarb | 3-(α-Methylphenethyl)-N-(phenylcarbamoyl)sydnone imine | |
Methylphenobarbital | 5-Ethyl-1-methyl-5-phenylbarbituric acid | |
Methylprylon | 3,3-Diethyl-5-methyl-2,4-piperidinedione | |
Midazolam | 8-Chloro-6-(o-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine | |
Nimetazepam | 1,3-Dihydro-1-methyl-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-one | |
Nitrazepam | 1,3-Dihydro-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-one | |
Nordazepam | 7-Chloro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one | |
Oxazepam | 7-Chloro-1,3-dihydro-3-hydroxy-5-phenyl-2H-1,4-benzodiazepin-2-one | |
Oxazolam | 10-Chloro-2,3,7,11b-tetrahydro-2-methyl-11b-phenyloxazolo[3,2-d][1,4]benzodiazepin-6(5H)-one | |
Pemoline | 2-Amino-5-phenyl-2-oxazolin-4-one | |
Phendimetrazine | (+)-(2S,3S)-3,4-Dimethyl-2-phenylmorpholine | |
Phenobarbital | 5-Ethyl-5-phenylbarbituric acid | |
Phenazepam | 7-Bromo-5-(2-chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one | |
Phentermine | α,α-Dimethylphenethylamine | |
Pinazepam | 7-Chloro-1,3-dihydro-5-phenyl-1-(2-propynyl)-2H-1,4-benzodiazepin-2-one | |
Pipradrol | 1,1-Diphenyl-1-(2-piperidyl)methanol | |
Prazepam | 7-Chloro-1-(cyclopropylmethyl)-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one | |
Pyrovalerone | 4'-Methyl-2-(1-pyrrolidinyl)valerophenone | |
Secbutabarbital | 5-sec-Butyl-5-ethylbarbituric acid | |
Temazepam | 7-Chloro-1,3-dihydro-3-hydroxy-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one | |
Tetrazepam | 7-Chloro-5-(1-cyclohexen-1-yl)-1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one | |
Triazolam | 8-Chloro-6-(o-chlorophenyl)-1-methyl-4H-s-triazolo[4,3-a][1,4]benzodiazepine | |
Vinylbital | 5-(1-Methylbutyl)-5-vinylbarbituric acid | |
Zolpidem | N,N,6-Trimethyl-2-p-tolylimidazo[1,2-a] pyridine-3-acetamide |
The salts of the substances listed in this Schedule whenever the existence of such salts is possible.
Voetnoten
This INN refers to only one of the stereochemical variants of delta-9-tetrahydrocannabinol, namely (−)-trans-delta-9-tetrahydrocannabinol.